02 2007 egfr - moleculaire-pathologie.nl moleculaire dag 020207...pcr success in frozen vs paraffin...
TRANSCRIPT
EGFREGFRtyrosine kinase mutations and copy number in tyrosine kinase mutations and copy number in
nonnon--small cell lung cancer small cell lung cancer
0202--0202--20072007
Mariëlle Gallegos RuizMariëlle Gallegos Ruiz
Contents
Introduction
EGFR
EGFR Inhibitors
EGFR mutations Techniques
Paraffin versus Frozen (Study I)
DNA versus RNA (Study II)
EGFR copy number
CISH versus FISH (Study III)
Conclusions
Future Directions
Extracellulardomain
Trans-membranedomain
Intracellulardomain
TyrosineKinase (TK)domain
Member of a subfamily of four closely related receptors
EGFR/Her1 (ErbB-1),
Her 2/neu (ErbB-2),
Her 3 (ErbB-3)
Her 4 (ErbB-4)
Epidermal Growth Factor Receptor
EGFR overexpressed in: Non Small Cell Lung Cancer
Esophagus cancer
Breast cancer
Head and neck cancer
Prostate cancer
Glioblastoma
EGFR Signaling
EGFR inhibition is a rationale for cancer treatment
Monoclonal antibodies; block binding of ligand
EGFR tyrosine kinase inhibitors (TKIs); block signaling
Iressa (gefitinib)
Tarceva (erlotinib)
EGFR Inhibitors
TK inhibitors have shown to be effective in 10-20% of unselected patients with NSCLC
Most responses seen inAdenocarcinoma
Females
Never smokers
East-Asian patients
EGFR mutations in NSCLC
Mutation in TK domain of EGFR correlates with response to TK inhibitors in NSCLC patients (Lynch, 2004; Paez, 2004; Pao, 2004)
85% of responders are mutated in EGFR TK domain90% exon 19 deletions and exon 21 L858R point mutations
Mutations in K-ras predict primary resistance to TKIs
EGFR and K-ras mutation analysis can be of help in identifying patients most likely to respond to EGFR TK inhibitors gefitinib and erlotinib
EGFR mutations - techniques
Introduction
EGFR
EGFR Inhibitors
EGFR mutations Techniques
Paraffin versus Frozen (Study I)
DNA versus RNA (Study II)
EGFR copy number
CISH versus FISH (Study III)
Conclusions
Future Directions
PCR and direct sequencing
WT EGFR Exon 19
MUT EGFR Exon 19
Detector
Capillary
detection of labelled nucleotides
Signal
EGFR Exon 19
Deletion A746-E750
EGFR Exon 21
Substitution T>G
AA change
Leucine to Arginine
PCR and direct sequencing
Advantages
Analytical sensitivity 10-30%
Every nucleotide change can be detected
Disadvantages
Time consuming
WT EGFR Exon 19
MUT EGFR Exon 19
FAM
FAM
detection of FAM label, separation by sizeDetector
Capillary
Signal
204 bp189 bp
Mutant EGFR Exon 19
15 bp deletion
Mutant EGFR Exon 19
9 bp deletion
204 bp
195 bp
15 bp difference
204 bp
Wild Type EGFR Exon 19
9 bp difference
Separation by size
EGFR exon 19 deletions
FAM
101 bp (wild type)
92 bp (mutant)
92 101
H1975 T790M
101
WT sample
PCR RFLP based analysis
EGFR exon 20 T790M
PCR RFLP based analysis
EGFR exon 21 L858R
Exon 21 CGG
Sau 96I Sau 96I
FAMPCR
Digest with SAu96I
or
180 bp (wild type)
91+180 bp (mutant)
H3255 L858R WT sample
PCR RFLP based analysis
Advantages
Analytical sensitivity 10-30%
Easy to perform
Disadvantages
Only known mutations can be detected
Limited enzymes available
Wild Type Mutant
Single Stranded Conformation Polymorphism (SSCP)
WTG12C
WTG12A
SSCP for K-ras
Advantages
Easy to perform
Quick screening, distinction mutation/wild type
Disadvantages
Sensitivity (our experience)
Need to confirm with sequencing
Single Stranded Conformation Polymorphism (SSCP)
DHPLC WAVE system
transgenomics
Fragment collection followed by direct sequencing
Advantages
Analytical sensitivity 1-5%
Disadvantages
False positives - importance of mutations
Time consuming
Expensive equipment
DHPLC WAVE system
Transgenomics
Several methods available
Optimal method seems to be PCR and sequencing
Summary
How does source of samples (paraffin – frozen) affects mutation analysis using PCR and sequencing?
How does template (gDNA – mRNA) affects mutation analysis using PCR and sequencing?
Study I
Introduction
EGFR
EGFR Inhibitors
EGFR mutations Techniques
Paraffin versus Frozen (Study I)
DNA versus RNA (Study II)
EGFR copy number
CISH versus FISH (Study III)
Conclusions
Future Directions
Frozen tissue is most probably best source for analysis
Most tissue is preserved fixed and embedded in paraffin
Various artifactual EGFR mutations have been described
AIM: To evaluate the effect of tissue processing and preservation on EGFR and K-ras mutation analysis
Frozen versus Paraffin
Experimental set up
47 NSCLC patientscollect paraffin specimens (47)
20 fixed in neutral buffered formalin27 fixed in sublimate formalin
collect frozen specimens (47)
Cut 15 subsequent slides
Pathologist verifies tumor percentage >50% before and after cutting of slides
EGFRexon 18exon 19exon 20exon 21
PCRK-ras
exon 1exon 2
Sequence PCR products
Isolate DNAQiagen kit Trizol
PCR success in frozen vs paraffin
Performed PCR for EGFR 18-19-20-21 and K-ras 1-2
Determined success rate in paraffin versus frozen
0
20
40
60
80
100
EGFR Exon 18(248 bp)
EGFR Exon 19(225 bp)
EGFR Exon 20(325 bp)
EGFR Exon 21(301 bp)
Kras Exon 1(253 bp)
Kras Exon 2(295 bp)
DNA fragment (length)
Rat
e of su
cess
ful P
CR
am
plif
icat
ion (%
)Frozen
FPER
ate
of
succ
ess
ful P
CR
am
plifi
cati
on
(%
)
Effect of product size
K-ras exon 2 success rate in paraffin was only 19%
Shortening the product size with 60 bp increased the success rate from 19% to 61%
0
10
20
30
40
50
60
70
Kras Exon 2(295 bp)
Kras Exon 2(235 bp)
DNA fragment (lenght)
Rat
e o
f su
cess
ful P
CR
am
plif
icat
ion
(%
)R
ate
of
succ
ess
ful P
CR
am
plifi
cati
on
(%
)
Effect of type of fixative on PCR success rate
47 fixed and paraffin embedded specimens
20 fixed in neutral buffered formalin
27 fixed in sublimate formalin
Does type of fixative influences PCR success rate?
0
20
40
60
80
100
Neutral buffered formalin Sublimate formalin
Fixative
Rat
e o
f su
cces
sfu
l PC
R a
mp
lific
atio
ns
(%)
PCR successfulP = <.0001
product size
shorter product results in higher success rate
type of fixativesuccess rate in neutral buffered formalin higher than in sublimate formalin fixed samples
Summary – PCR success rate
storage time
no significant influence
time of fixation
shown by Inoue et al (1996) that fixation for 2-3 days results in failure of 56% of PCRs as compared to fixation for 1 day
not determinable in our study
Results
Sequencing EGFR exon 20 sample 3977909
GGC Gly 779
GGC Gly 779
GGC > AGC Gly 779 Ser
Frozen FPE FPE re-analyzed
13 mutations detected in EGFR
3 previously described mutations, detected in frozen and paraffin
10 not previously identified mutations detected only in paraffin specimens
repeated analysis of these samples revealed a wild type sequence
10 mutations detected in K-ras
all previously described mutations, detected in frozen and paraffin
Tsao et al (2005) reported 24 ‘novel’ EGFR mutationsNot confirmed by repeated analysis
Fixation and paraffin embedding of samples can result in deamination of cytosine residues (Marchetti, 2005)
Use of this damaged DNA as template can result in artifactual C>T or G>A transitions
Artifactual mutations
# Fixative Artifactual mutation Nucleotide Change
7876980 Sublimate Formalin Ala 722 Val C>T
1989395 Sublimate Formalin Cys 781 Cys C>T
4987459 Sublimate Formalin Leu 792 Leu C>T
0951411 Sublimate Formalin Leu 858 Leu C>T
6123993 Sublimate Formalin Leu 858 Leu C>T
5148421 Neutral Buffered Formalin Pro 733 Ser C>T
5148422 Neutral Buffered Formalin Glu 746 Lys G>A
3977909 Neutral Buffered Formalin Gly 779 Ser G>A
3977909 Neutral Buffered Formalin Glu 804 Lys G>A
3977909 Neutral Buffered Formalin Ala 822 Thr G>A
When using paraffin samples use primers which give products as short as possible
Confirm mutations by repeated analysis
Frozen tissue is the preferable source for analysis
Conclusion study I
Study II
Introduction
EGFR
EGFR Inhibitors
EGFR mutations Techniques
Paraffin versus Frozen (Study I)
DNA versus RNA (Study II)
EGFR copy number
CISH versus FISH (Study III)
Conclusions
Future Directions
Mutation analysis using PCR and sequencing on RNA as template saves time compared to using DNA as template
AIM: To determine possible differences between sensitivity of mutation analysis in genomic DNA versus mRNA
gDNA versus mRNA
Experimental set up
47 NSCLC patientscollect paraffin specimens (47)
20 fixed in neutral buffered formalin27 fixed in sublimate formalin
collect frozen specimens (47)
Cut 15 subsequent slides
Pathologist verifies tumor percentage >50% before and after cutting of slides
Isolate DNA Isolate RNA
EGFRexon 18exon 19exon 20exon 21
PCRK-ras
exon 1exon 2
Sequence PCR products
EGFRexon 18-21
PCRK-ras
exon 1-2
Sequence PCR products
Aqueous layer (RNA)
Interphase and trizol (DNA)
PCR amplification successful in 100% of samples,
in both gDNA and mRNA
Sensitivity of sequencinggDNA vs mRNA
3 EGFR mutations identified in 2 patients
P848L, detected with same accuracy in gDNA and mRNA
identified previously, not related with response to TKIs
S768I and L861Q, mutation signal higher in mRNA than in gDNA
SNP in this sample detected with same accuracy
10 K-ras mutation detected with same accuracy in
gDNA and mRNA
Sensitivity of sequencingDNA vs RNA
gDNA
CAA > CAGGln 787 Gln
CAA > CAGGln 787 Gln
RNA
gDNA
CTG > CAGLeu 861 Gln
CTG > CAGLeu 861 Gln
RNA
AGC > ATCSer 768 Ile
AGC > ATCSer 768 Ile
RNA
gDNA
Both gDNA and mRNA can be used for mutation analysis
Some EGFR mutations may be easier to identify by using mRNA as template
mutant allele overexpressed?
Conclusion study II
Study III
Introduction
EGFR
EGFR Inhibitors
EGFR mutations Techniques
Paraffin versus Frozen (Study I)
DNA versus RNA (Study II)
EGFR copy number
CISH versus FISH (Study III)
Conclusions
Future Directions
High polysomy and amplification of EGFR gene correlates with favorable outcome after treatment with gefitinib and better survival (FISH) (Capuzzo, 2005; Hirsch, 2005)
High EGFR copy number associated with longer survival in patients treated with erlotinib (FISH) (Tsao, 2005)
EGFR copy number as assessed by Real time PCR failed to obtain predictive and prognostic information (Bell, 2005; Dziadziuszko, 2005)
EGFR copy number
EGFR copy number detection using FISH can be of importance in selecting patients for treatment with TK inhibitors
FISH technique some disadvantagesFluorescent microscope needed
Fading of signal
Morphology limited
These disadvantages can be overcome by Chromogenic In Situ Hybridization, CISH
Implementing CISH to determine EGFR copy number may be of practical value
EGFR copy number FISH and CISH
Fluorescent In Situ Hybridization
Denaturation
F
Chromogenic In Situ Hybridization
DIG
Mouse-α-DIG
EGFR-probe
**
**
DAB oxidized DAB
Denaturation
Envision HRP
Collect 58 tumor samples on which CISH was successfully performed
31 paraffin samples
27 frozen samples
Apply FISH and CISH on all samples
Count 200 cells in at least three representative fields≤ 4 dots in > 40% of cells no/low genomic gain
≥ 4 dots in ≥ 40% of cells high polysomy
≥ 15 dots or clusters in 10% amplification
Experimental set up and scoring
Success rate
FISH CISH FISH CISH
Easily assessable 19 13 6 26
Difficult to assess 8 14 11 5
Not assessable 0 0 14 0
Number of samples defined by success rate
Frozen (n=27) Paraffin (n=31)
Success rates for FISH and CISH in relation to source of the sample
Reasons of FISH failure
Autofluorescence (4)
Detachment of tissue (5)
Unrecognizable morphology (4)
Low signal (1)
Reasons of difficulties CISH
High Background
Concordance between observers
Cases with different outcome between observers for CISH
Case # OB1 OB2
34 30 (-) 43 (+)
36 23 (-) 44 (+)
44 25 (-) 66 (+)
39 43 (+) 13 (-)
Percentage of cells with ≥4 copies per nucleus (CISH)
CISH concordance 93% (Kappa coefficient 0.74)
FISH concordance 100% (Kappa coefficient 1)
Concordance between techniques
Concordance observer 1: 93% (Kappa coefficient 0.64)
Concordance observer 2: 95% (Kappa coefficient 0.76)
Correlation between FISH and CISH results for both observers
Positive Negative Positive Negative
Positive 4 1 4 0
Negative 2 37 2 38
FISH
Observer 1 Observer 2
CISH
EGFR disomy
EGFR high polysomy
EGFR amplification
High concordance found between techniques and observers
CISH is a useful alternative strategy to detect EGFR gene copy number
CISH preferable in paraffin section
FISH preferable in frozen sections
Conclusion study III
Detection of EGFR and K-ras mutations
Paraffin samples
Use primers as short as possible
Confirm mutation by independent analysis
Frozen samples
Preferable for use
Detection of EGFR copy number
Paraffin samples
Use Chromogenic In Situ Hybridization
Frozen samples
Use Fluorescent In Situ Hybridization
Future directions
Department of Medical Oncology, VUMC
Karijn Floor
José Antonio Rodriguez
Giuseppe Giaccone
Department of Pathology, VUMC
Katrien Grünberg
Gerrit Meijer
Erik Thunnissen
Acknowledgements